Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability

Open access

Abstract

p32 is an evolutionarily conserved and ubiquitously expressed multifunctional protein. Although p32 exists at diverse intra and extracellular sites, it is predominantly localized to the mitochondrial matrix near the nucleoid associated with mitochondrial transcription factor A. Nonetheless, its function in the matrix is poorly understood. Here, we determined p32 function via generation of p32-knockout mice. p32-deficient mice exhibited mid-gestation lethality associated with a severe developmental defect of the embryo. Primary embryonic fibroblasts isolated from p32-knockout embryos showed severe dysfunction of the mitochondrial respiratory chain, because of severely impaired mitochondrial protein synthesis. Recombinant p32 binds RNA, not DNA, and endogenous p32 interacts with all mitochondrial messenger RNA species in vivo. The RNA-binding ability of p32 is well correlated with the mitochondrial translation. Co-immunoprecipitation revealed the close association of p32 with the mitoribosome. We propose that p32 is required for functional mitoribosome formation to synthesize proteins within mitochondria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gks774

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Disruption of p32 causes embryonic lethality. (A) Whole mounts of E10.5 p32−/− embryos and histological analysis of p32−/− embryos compared with those of wild-type p32+/+ littermates. Photomicrographs (upper left) and hematoxylin and eosin (HE) staining (upper right) are shown. Pregnant mice were injected with BrdU at 2 h prior to dissection. Sections of p32+/+ and p32−/− embryos at E10.5 were stained with BrdU (lower left) or an anti-p32 antibody (lower right). In vivo labeling with BrdU revealed arrest of proliferation in E10.5 embryos. Scale bars: 500 µm. (B) Immunofluorescence staining of p32 and MitoTracker Red in wild-type and p32-knockout cells. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). MEFs were treated with MitoTracker Red (500 nM) for 20 min before p32 staining. Cells were fixed, fluorescently stained by anti-p32 antibodies, and then analyzed by confocal microscopy. The lower panel shows merged images. Scale bar: 20 μm.
Figure 1. Disruption of p32 causes embryonic lethality. (A) Whole mounts of E10.5 p32−/− embryos and histological analysis of p32−/− embryos compared with those of wild-type p32+/+ littermates. Photomicrographs (upper left) and hematoxylin and eosin (HE) staining (upper right) are shown. Pregnant mice were injected with BrdU at 2 h prior to dissection. Sections of p32+/+ and p32−/− embryos at E10.5 were stained with BrdU (lower left) or an anti-p32 antibody (lower right). In vivo labeling with BrdU revealed arrest of proliferation in E10.5 embryos. Scale bars: 500 µm. (B) Immunofluorescence staining of p32 and MitoTracker Red in wild-type and p32-knockout cells. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). MEFs were treated with MitoTracker Red (500 nM) for 20 min before p32 staining. Cells were fixed, fluorescently stained by anti-p32 antibodies, and then analyzed by confocal microscopy. The lower panel shows merged images. Scale bar: 20 μm.CC BY-NC · PubMed Central
Figure 2. Reduced mitochondrial respiratory activities in p32−/− MEFs. (A) The activity of each complex was measured using cell lysates as described in ‘Materials and Methods’ section. Reduced enzymatic activities of mitochondrial complexes I, III and IV in p32-knockout cells were observed. In contrast, complex II activity was not decreased. Re-expression of p32 in p32−/− cells restored the enzymatic activities of complexes I, III and IV. The results represent the mean ± SD of three independent experiments. *P < 0.05; **P < 0.01 versus controls (p32+/+ versus p32−/− and p32−/− versus p32−/−::p32). (B) Oxygen consumption by digitonin-permeabilized wild-type (p32+/+) and knockout (p32−/−) MEFs. Glutamate and malate (glu+mal) respiration depends on the activities of complexes I, III and IV; glycerol-3-phosphate and succinate (G3P+suc) respiration depends on the activities of complexes III and IV. Rotenone (a complex I inhibitor) and Antimycin A (a complex III inhibitor) completely inhibit O2 consumption at each step. Data show the mean ± SD of triplicate experiments and **P < 0.01 versus controls (p32+/+ versus p32−/−). (C) Decreased mitochondrial membrane potential in p32-knockout MEFs. MEFs were stained with the fluorescent dye JC-1 and then analyzed by flow cytometry at 527 and 590 nm. The fluorescence ratio of JC1 dimer (Red)/JC-1 monomer (Green) is shown. Dissipation of the membrane potential with CCCP was used as a control. (D) Effects of 2-deoxy-d-glucose (2DG) (20 mM) and oligomycin (10 μM) on intracellular ATP content in MEFs. The ATP content in untreated MEFs is presented in lane 1. The ATP concentration of untreated MEFs (lane 1) was subtracted from that of 2DG-treated MEFs (lane 2) for assessment of glycolytic ATP production (lanes 1 and 2). The ATP concentration in 2DG-treated cells (lane 2) was subtracted from that in cells treated with 2DG + oligomycin (lane 3) for mitochondrial ATP production (lanes 2–3). Wild-type (p32+/+), p32-knockout (p32−/−), re-expressed p32 (p32−/−::p32) and vector only-transfected (p32−/−::vector) MEFs were used. The ATP response was measured using a Luminescence ATP assay kit in a 96-well plate. Data show the mean ± SD of triplicate experiments. (E) Cell proliferation monitored in MEFs. Upper panel: the diamonds, squares, triangles and circles represent wild-type MEFs (p32+/+), p32-knockout MEFs (p32−/−), knockout MEFs with reintroduced p32 cDNA (p32−/−::p32) and knockout MEFs with introduced vector-only cDNA (p32−/−::vector), respectively. Lower panel: pyruvate (1 mM) was added to wild-type and p32−/− MEFs. The cell number was counted at 24, 48, 72 and 96 h after seeding. Here, we used DMEM (1000 mg/l glucose) supplemented with 10% dialyzed FBS without pyruvate.
Figure 2. Reduced mitochondrial respiratory activities in p32−/− MEFs. (A) The activity of each complex was measured using cell lysates as described in ‘Materials and Methods’ section. Reduced enzymatic activities of mitochondrial complexes I, III and IV in p32-knockout cells were observed. In contrast, complex II activity was not decreased. Re-expression of p32 in p32−/− cells restored the enzymatic activities of complexes I, III and IV. The results represent the mean ± SD of three independent experiments. *P < 0.05; **P < 0.01 versus controls (p32+/+ versus p32−/− and p32−/− versus p32−/−::p32). (B) Oxygen consumption by digitonin-permeabilized wild-type (p32+/+) and knockout (p32−/−) MEFs. Glutamate and malate (glu+mal) respiration depends on the activities of complexes I, III and IV; glycerol-3-phosphate and succinate (G3P+suc) respiration depends on the activities of complexes III and IV. Rotenone (a complex I inhibitor) and Antimycin A (a complex III inhibitor) completely inhibit O2 consumption at each step. Data show the mean ± SD of triplicate experiments and **P < 0.01 versus controls (p32+/+ versus p32−/−). (C) Decreased mitochondrial membrane potential in p32-knockout MEFs. MEFs were stained with the fluorescent dye JC-1 and then analyzed by flow cytometry at 527 and 590 nm. The fluorescence ratio of JC1 dimer (Red)/JC-1 monomer (Green) is shown. Dissipation of the membrane potential with CCCP was used as a control. (D) Effects of 2-deoxy-d-glucose (2DG) (20 mM) and oligomycin (10 μM) on intracellular ATP content in MEFs. The ATP content in untreated MEFs is presented in lane 1. The ATP concentration of untreated MEFs (lane 1) was subtracted from that of 2DG-treated MEFs (lane 2) for assessment of glycolytic ATP production (lanes 1 and 2). The ATP concentration in 2DG-treated cells (lane 2) was subtracted from that in cells treated with 2DG + oligomycin (lane 3) for mitochondrial ATP production (lanes 2–3). Wild-type (p32+/+), p32-knockout (p32−/−), re-expressed p32 (p32−/−::p32) and vector only-transfected (p32−/−::vector) MEFs were used. The ATP response was measured using a Luminescence ATP assay kit in a 96-well plate. Data show the mean ± SD of triplicate experiments. (E) Cell proliferation monitored in MEFs. Upper panel: the diamonds, squares, triangles and circles represent wild-type MEFs (p32+/+), p32-knockout MEFs (p32−/−), knockout MEFs with reintroduced p32 cDNA (p32−/−::p32) and knockout MEFs with introduced vector-only cDNA (p32−/−::vector), respectively. Lower panel: pyruvate (1 mM) was added to wild-type and p32−/− MEFs. The cell number was counted at 24, 48, 72 and 96 h after seeding. Here, we used DMEM (1000 mg/l glucose) supplemented with 10% dialyzed FBS without pyruvate.CC BY-NC · PubMed Central
Figure 3. MtDNA copy number, RNA and protein expression in p32−/− MEFs. (A) The amount of mtDNA per cell was estimated based on the ratio of mtDNA/nuclear (n)DNA (ND2/AT-III). The relative mtDNA amount between p32−/− and p32+/+ cells is shown. (B) Real-time PCR quantification of mitochondrial gene transcript levels isolated from wild-type (p32+/+) MEFs, p32-knockout (p32−/−) MEFs, and knockout MEFs with reintroduced p32 cDNA (p32−/−::p32). Two nuclear-encoded RNA species (β-actin and 18S rRNA) were also quantified. Data were normalized to the expression level in wild-type p32+/+ MEFs for each RNA species. Data show the mean ± SD of triplicate experiments and *P < 0.05; versus controls (p32+/+ versus p32−/−). (C) Expression of mitochondrial proteins. Crude mitochondria were prepared from equal amounts of MEFs. Ten micrograms of protein for each sample was loaded. Blots were incubated with the indicated antibodies. Lane 1, wild-type MEFs; lane 2, p32-knockout MEFs; lane 3, knockout MEFs with reintroduced p32 cDNA; lane 4, knockout MEFs with introduced vector-only cDNA. Mt: OXPHOS protein encoded by mitochondria DNA; N: OXPHOS protein encoded by the nucleus. (D) In vivo mitochondrial translation was performed for 60 min using the cell lysates. The products were labeled during the reaction with a mixture of [35S]-methionine and [35S]-cysteine in the presence of emetine and/or chloramphenicol, and then detected by autoradiography after SDS–PAGE (upper panel). Deficient translation was observed in p32-knockout cells (lane 3). Equal loading was confirmed by CBB staining following exposure (lower panel). Lanes 1 and 2, wild-type MEFs; lane 3, p32-knockout MEFs; lane 4, knockout MEFs with reintroduced p32 cDNA; lane5, knockout MEFs with introduced p32::K89A/K93A mutant; lane 6, knockout MEFs with vector-only cDNA. The protein indicated are representative proteins based on their molecular weight.
Figure 3. MtDNA copy number, RNA and protein expression in p32−/− MEFs. (A) The amount of mtDNA per cell was estimated based on the ratio of mtDNA/nuclear (n)DNA (ND2/AT-III). The relative mtDNA amount between p32−/− and p32+/+ cells is shown. (B) Real-time PCR quantification of mitochondrial gene transcript levels isolated from wild-type (p32+/+) MEFs, p32-knockout (p32−/−) MEFs, and knockout MEFs with reintroduced p32 cDNA (p32−/−::p32). Two nuclear-encoded RNA species (β-actin and 18S rRNA) were also quantified. Data were normalized to the expression level in wild-type p32+/+ MEFs for each RNA species. Data show the mean ± SD of triplicate experiments and *P < 0.05; versus controls (p32+/+ versus p32−/−). (C) Expression of mitochondrial proteins. Crude mitochondria were prepared from equal amounts of MEFs. Ten micrograms of protein for each sample was loaded. Blots were incubated with the indicated antibodies. Lane 1, wild-type MEFs; lane 2, p32-knockout MEFs; lane 3, knockout MEFs with reintroduced p32 cDNA; lane 4, knockout MEFs with introduced vector-only cDNA. Mt: OXPHOS protein encoded by mitochondria DNA; N: OXPHOS protein encoded by the nucleus. (D) In vivo mitochondrial translation was performed for 60 min using the cell lysates. The products were labeled during the reaction with a mixture of [35S]-methionine and [35S]-cysteine in the presence of emetine and/or chloramphenicol, and then detected by autoradiography after SDS–PAGE (upper panel). Deficient translation was observed in p32-knockout cells (lane 3). Equal loading was confirmed by CBB staining following exposure (lower panel). Lanes 1 and 2, wild-type MEFs; lane 3, p32-knockout MEFs; lane 4, knockout MEFs with reintroduced p32 cDNA; lane5, knockout MEFs with introduced p32::K89A/K93A mutant; lane 6, knockout MEFs with vector-only cDNA. The protein indicated are representative proteins based on their molecular weight.CC BY-NC · PubMed Central
Figure 4. Reduction of p32 results in decreased mitoribosomes. (A) Upper panels: Sedimentation analysis of mitoribosomal particles by centrifugation via a linear 15–30% sucrose density gradient. Fraction numbers are indicated. The migration of mitoribosomal particles in wild-type (+/+), p32-knockout (−/−) MEFs and p32 re-expressed (−/−::p32) MEFs was determined by immunoblotting with antibodies against MRPL3 (39S large subunit), MRPS29 (28S small subunit) and p32. Arrows indicate peaks of optical density for the S value markers. Asterisk (*) shows non-specific band of MRPL3 and p32 at top fraction (1–2). (B) Representative blots were analyzed densitometrically. The signal intensity of the protein in each fraction was plotted. The maximum value was 100% for each protein level.
Figure 4. Reduction of p32 results in decreased mitoribosomes. (A) Upper panels: Sedimentation analysis of mitoribosomal particles by centrifugation via a linear 15–30% sucrose density gradient. Fraction numbers are indicated. The migration of mitoribosomal particles in wild-type (+/+), p32-knockout (−/−) MEFs and p32 re-expressed (−/−::p32) MEFs was determined by immunoblotting with antibodies against MRPL3 (39S large subunit), MRPS29 (28S small subunit) and p32. Arrows indicate peaks of optical density for the S value markers. Asterisk (*) shows non-specific band of MRPL3 and p32 at top fraction (1–2). (B) Representative blots were analyzed densitometrically. The signal intensity of the protein in each fraction was plotted. The maximum value was 100% for each protein level.CC BY-NC · PubMed Central
Figure 5. p32 interaction with RNA and the mitoribosome. (A) p32 is associated with mitochondrial RNA in HeLa cells. p32-HA expression in HeLa cells was induced with doxycycline (DOX+) or not (DOX–). HA-tagged p32 was immunoprecipitated (left panel). LRPPRC was also immunoprecipitated using the LRPPRC antibody and confirmed the IP by western blotting (right panel). The each RNA levels were measure by qPCR and the ratio of each RNA level (LRPPRC/IgG) is shown for mitochondria- and nuclear-encoded genes. (B) In MEF cells, p32 were immunoprecipitated using the p32 antibody. Then RNA was extracted from the immunoprecipitated samples and each RNA species was measured by qPCR as described in the materials and methods. The ratio of each RNA level (p32/ IgG) is shown for mitochondria- and nuclear-encoded genes. (C) Co-IP of RNA visualized on northern blot analysis in HeLa cells. RNA from whole-cell lysates (lanes 1 and 2) and immunoprecipitants with anti-HA (lanes 3 and 4) were loaded on gels. Northern blot analysis was performed using ND1, COX1 and β-actin probes.
Figure 5. p32 interaction with RNA and the mitoribosome. (A) p32 is associated with mitochondrial RNA in HeLa cells. p32-HA expression in HeLa cells was induced with doxycycline (DOX+) or not (DOX–). HA-tagged p32 was immunoprecipitated (left panel). LRPPRC was also immunoprecipitated using the LRPPRC antibody and confirmed the IP by western blotting (right panel). The each RNA levels were measure by qPCR and the ratio of each RNA level (LRPPRC/IgG) is shown for mitochondria- and nuclear-encoded genes. (B) In MEF cells, p32 were immunoprecipitated using the p32 antibody. Then RNA was extracted from the immunoprecipitated samples and each RNA species was measured by qPCR as described in the materials and methods. The ratio of each RNA level (p32/ IgG) is shown for mitochondria- and nuclear-encoded genes. (C) Co-IP of RNA visualized on northern blot analysis in HeLa cells. RNA from whole-cell lysates (lanes 1 and 2) and immunoprecipitants with anti-HA (lanes 3 and 4) were loaded on gels. Northern blot analysis was performed using ND1, COX1 and β-actin probes.CC BY-NC · PubMed Central
Figure 6. p32 binds to RNA oligonucleotides in vitro. (A) Upper: diagram of alignment in the α helix I of Homo sapiens, Mus musculus, Pan troglodytes, Canis lupus, Bos taurus and Rattus norvegicus p32. K89 and K93 in mouse p32 are shown as bold. Lower: purified wild-type and mutant p32, but not recombinant TFAM-His and GST proteins, bind to poly(A) oligonucleoside. Protein–poly(A) RNA complexes were separated by a REMSA using a 6% native polyacrylamide gel. An arrow indicates free probe. Recombinant wild-type and mutant proteins (2–20 μM) were incubated with 22-mer poly(A) RNA and then separated by a REMSA. Purified p32 bind to poly(A) oligonucleotide prefer to mutant p32. (B) The indicated amount of wild-type His-p32 and mutant His-p32 (K89A/K93A) fusion protein was incubated with 32P-labeled random 14-mer RNA, 40-mer RNA, 22-mer poly(A) RNA, 22-mer poly(U) RNA or 22-mer poly(A) DNA oligonucleotides at 25°C for 30 min. p32–oligonucleotide complexes were separated by a electrophoretic REMSA using a 6% native polyacrylamide gel. The arrow indicates free probe. (C) Competition assays were performed by adding unlabeled RNA or DNA. The indicated fold amount of unlabeled RNA or DNA (0.2×, 1.0× or 5.0× relative to the 32P-labeled probe) was incubated with recombinant p32 (4 μM) and 32P-labeled poly(A) RNA; the complexes were separated by native polyacrylamide gel electrophoresis. The arrow indicates free probe. The lower panel indicates the intensity of the complex band. The 100% value represents the intensity of the complex of recombinant p32 and 32P-labeled poly(A) RNA. (D) Expression of mitochondrial proteins. Cell lysates were prepared from equal amounts of wild-type MEFs, p32-knockout MEFs and MEFs with reintroduced wild-type p32 cDNA, vector-only cDNA and mutant K89A/K93A p32 cDNA. Blots were incubated with antibodies for the indicated proteins.
Figure 6. p32 binds to RNA oligonucleotides in vitro. (A) Upper: diagram of alignment in the α helix I of Homo sapiens, Mus musculus, Pan troglodytes, Canis lupus, Bos taurus and Rattus norvegicus p32. K89 and K93 in mouse p32 are shown as bold. Lower: purified wild-type and mutant p32, but not recombinant TFAM-His and GST proteins, bind to poly(A) oligonucleoside. Protein–poly(A) RNA complexes were separated by a REMSA using a 6% native polyacrylamide gel. An arrow indicates free probe. Recombinant wild-type and mutant proteins (2–20 μM) were incubated with 22-mer poly(A) RNA and then separated by a REMSA. Purified p32 bind to poly(A) oligonucleotide prefer to mutant p32. (B) The indicated amount of wild-type His-p32 and mutant His-p32 (K89A/K93A) fusion protein was incubated with 32P-labeled random 14-mer RNA, 40-mer RNA, 22-mer poly(A) RNA, 22-mer poly(U) RNA or 22-mer poly(A) DNA oligonucleotides at 25°C for 30 min. p32–oligonucleotide complexes were separated by a electrophoretic REMSA using a 6% native polyacrylamide gel. The arrow indicates free probe. (C) Competition assays were performed by adding unlabeled RNA or DNA. The indicated fold amount of unlabeled RNA or DNA (0.2×, 1.0× or 5.0× relative to the 32P-labeled probe) was incubated with recombinant p32 (4 μM) and 32P-labeled poly(A) RNA; the complexes were separated by native polyacrylamide gel electrophoresis. The arrow indicates free probe. The lower panel indicates the intensity of the complex band. The 100% value represents the intensity of the complex of recombinant p32 and 32P-labeled poly(A) RNA. (D) Expression of mitochondrial proteins. Cell lysates were prepared from equal amounts of wild-type MEFs, p32-knockout MEFs and MEFs with reintroduced wild-type p32 cDNA, vector-only cDNA and mutant K89A/K93A p32 cDNA. Blots were incubated with antibodies for the indicated proteins.CC BY-NC · PubMed Central
Figure 7. p32 interact with several ribosomal protein. p32-HA expression in HeLa cells was induced with doxycycline (DOX+) or not (DOX–). Lysed mitochondria were immunoprecipitated with anti-HA agarose (left panel), and a lysate of p32+/+ MEFs was immunoprecipitated with an anti-p32 antibody (right panel) followed by western blotting with antibodies for the indicated proteins.
Figure 7. p32 interact with several ribosomal protein. p32-HA expression in HeLa cells was induced with doxycycline (DOX+) or not (DOX–). Lysed mitochondria were immunoprecipitated with anti-HA agarose (left panel), and a lysate of p32+/+ MEFs was immunoprecipitated with an anti-p32 antibody (right panel) followed by western blotting with antibodies for the indicated proteins.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 171

Metadata

Authors
Yagi, M., Uchiumi, T., Takazaki, S., Okuno, B., Nomura, M., Yoshida, S.-I., Kanki, T., & Kang, D.
Affiliations
Kyushu University (JP)
Corresponding author
Uchiumi, Takeshi
Venue
Nucleic Acids Research
Published
2012-08-13
Volume
40
Issue
19
Pages
9717-9737
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2008542507
Cited by
169
References
55
Citations by year
2026: 5 · 2025: 9 · 2024: 10 · 2023: 28 · 2022: 17 · 2021: 17 · 2020: 19 · 2019: 11 · 2018: 12 · 2017: 13 · 2016: 8 · 2015: 8 · 2014: 6 · 2013: 6
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology (21590337, 19209019)
  • Japan Society for the Promotion of Science (21590337, 23790370, 24590387, 23689032, 22249018, 19209019, 24659281)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
mitochondrial translation, mitochondrial ribosome, RNA-binding proteins, fetal development, mitochondrial respiratory chain, embryonic fibroblasts, mitochondrial matrix
MeSH terms
RNA, Mitochondrial, Adenosine Triphosphate, Animals, Carrier Proteins, Cells, Cultured, DNA, Mitochondrial, Fibroblasts, Genes, Lethal, HeLa Cells, Humans, Mitochondria, Ribosomes, RNA, RNA, Messenger, Protein Biosynthesis, RNA-Binding Proteins, Mice, Knockout, Hyaluronan Receptors, Cell Respiration, Mitochondrial Proteins, Fetal Development, Cell Proliferation, Mice, Membrane Potential, Mitochondrial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability. https://app.cochat.ai/papers/10.1093/nar/gks774
The paper
Yagi, M., Uchiumi, T., Takazaki, S., Okuno, B., Nomura, M., Yoshida, S.-I., Kanki, T., & Kang, D. (2012). p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability. Nucleic Acids Research. https://doi.org/10.1093/nar/gks774

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.